Unknown

Dataset Information

2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease.


ABSTRACT:

Purpose of review

Provide an updated review of the clinical management and diagnosis of Kawasaki disease with inclusion of potential diagnostic difficulties with multisystem inflammatory syndrome in children (MIS-C) given the ongoing COVID-19 pandemic.

Recent findings

Adjunctive corticosteroid therapy has been shown to reduce the rate of coronary artery dilation in children at high risk for IVIG resistance in multiple Japanese clinical studies (most notably RAISE study group). Additional adjunctive therapies (etanercept, infliximab, cyclosporin) may also provide limited benefit, but data is limited to single studies and subgroups of patients with cardiac abnormalities. The efficacy of other agents (atorvastatin, doxycycline) is currently being investigated. MIS-C is a clinic

SUBMITTER: Zhu F 

PROVIDER: S-EPMC8851597 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature